Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
Male
Risk
570
Aging
Neuroimaging
Neurodegenerative
Alzheimer's Disease
Hippocampus
Polymorphism, Single Nucleotide
630
Article
03 medical and health sciences
0302 clinical medicine
Clinical Research
Alzheimer Disease
Health Sciences
Genetics
Acquired Cognitive Impairment
80 and over
2.1 Biological and endogenous factors
Humans
Genetic Predisposition to Disease
Polymorphism
Aged
Cerebrospinal Fluid
Aged, 80 and over
Amyloid beta-Peptides
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Single Nucleotide
Alzheimer’s Disease Neuroimaging Initiative
Organ Size
Biological Sciences
Brain Disorders
4.1 Discovery and preclinical testing of markers and technologies
3. Good health
Clusterin
Glucose
Neurological
Unfolded Protein Response
Dementia
Female
Biomarkers
DOI:
10.1038/srep26027
Publication Date:
2016-05-27T09:38:19Z
AUTHORS (251)
ABSTRACT
AbstractThe Clusterin (CLU) gene, also known as apolipoprotein J (ApoJ), is currently the third most associated late-onset Alzheimer’s disease (LOAD) risk gene. However, little was known about the possible effect of CLU genetic variants on AD pathology in brain. Here, we evaluated the interaction between 7 CLU SNPs (covering 95% of genetic variations) and the role of CLU in β-amyloid (Aβ) deposition, AD-related structure atrophy, abnormal glucose metabolism on neuroimaging and CSF markers to clarify the possible approach by that CLU impacts AD. Finally, four loci (rs11136000, rs1532278, rs2279590, rs7982) showed significant associations with the Aβ deposition at the baseline level while genotypes of rs9331888 (P = 0.042) increased Aβ deposition. Besides, rs9331888 was significantly associated with baseline volume of left hippocampus (P = 0.014). We then further validated the association with Aβ deposition in the AD, mild cognitive impairment (MCI), normal control (NC) sub-groups. The results in sub-groups confirmed the association between CLU genotypes and Aβ deposition further. Our findings revealed that CLU genotypes could probably modulate the cerebral the Aβ loads on imaging and volume of hippocampus. These findings raise the possibility that the biological effects of CLU may be relatively confined to neuroimaging trait and hence may offer clues to AD.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (76)
CITATIONS (48)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....